MYMD PHARMACEUTICALS INC (MYMD)
Institutional ownership reported to the SEC as of Q1 2024, across 12 quarters.
1
Reporting holders
$43
Reported value
0.0%
Held as options
-45
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| St. Johns Investment Management Company, LLC | $43 | 18 | 0.00% | 7q | -96.4%-$1.1K |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2024 | 1 | $43 | 18 | 0 | 0 | 1 | 0.0% |
| Q4 2023 | 46 | $1.7M | 6,356,793 | 6 | 9 | 9 | 1.6% |
| Q3 2023 | 48 | $2.6M | 4,241,174 | 13 | 10 | 10 | 5.1% |
| Q2 2023 | 40 | $6.6M | 4,210,133 | 3 | 12 | 3 | 4.7% |
| Q1 2023 | 44 | $7.0M | 3,938,069 | 14 | 9 | 6 | 3.7% |
| Q4 2022 | 33 | $4.1M | 3,455,410 | 5 | 9 | 7 | 3.9% |
| Q3 2022 | 43 | $10.5M | 3,805,522 | 17 | 7 | 8 | 5.1% |
| Q2 2022 | 34 | $10.3M | 4,698,619 | 7 | 3 | 13 | 0.0% |
| Q1 2022 | 33 | $23.5M | 4,961,939 | 3 | 5 | 11 | 1.7% |
| Q4 2021 | 40 | $29.5M | 4,583,182 | 11 | 12 | 6 | 5.8% |
| Q3 2021 | 29 | $42.1M | 5,803,059 | 9 | 7 | 5 | 0.8% |
| Q2 2021 | 23 | $30.8M | 4,878,138 | 23 | 0 | 0 | 0.3% |